Chronic glomerulonephritis: arguments for cyclosporine use


Cite item

Full Text

Abstract

Indications for cyclosporine use in chronic glomerulonephritis are discussed. evidence of cyclosporine efficacy in minimal change disease, focal and segmental glomerulosclerosis, membranous nephropathy and lupus nephritis are shown

About the authors

L V Kozlovskaya

References

  1. Baran D., Vendeville B., Vial M.C. et al. Effect of cyclosporine A on mercury-induced autoimmune glomerulonephritis in the Brown Norway rat. Clin. Nephrol. 1986; 25 (Suppl 1): S175-S180
  2. Thaiss F., Mihatsch M.J., Batsford S. et al. Effect of cyclosporine on in situ immune complex glomerulonephritis. Clin. Nephrol. 1986; 25 (Suppl 1): S181-S185
  3. Gunn H.C., Ryffel B. Glomerulonephritis in NZB/W mice: therapeutic effect of cyclosporine. Clin. Nephrol. 1986;25 (Suppl 1): S189-S192
  4. Waldo F.B., Kohaut E.C. Therapy of focal segmental glomerulosclerosis with cyclosporine A. Pediatr. Nephrol. 1987; 1(2): 180-182
  5. Meyrier A., Simon P. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Adv. Nephrol. Necker Hosp. 1988; 17: 127-150
  6. Meyrier A. Treatment of idiopathic nephrosis by immunophillin modulation. Nephrol. Dial. Transplant. 2003; 18(Suppl. 6): vi79-vi86
  7. Matsumoto H., Nakao T., Okada T. et al. Initial remission-inducing effect of very low-dose cyclosporine monotherapy for minimal-change nephrotic syndrome in Japanese adults. Clin. Nephrol. 2001; 55: 143-148
  8. Matsumoto H., Nakao T., Okada T. et al. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome. Intern. Med. 2004; 43(8): 668-673
  9. Eguchi A., Takei T., Yoshida T. et al. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome. Nephrol. Dial. Transplant. 2010; 25(1): 124-129
  10. Filler G. How should microemulsified cyclosporine A (Neoral) therapy in nephritic syndrome be monitored? Nephrol. Dial. Transplant. 2005; 20: 1032-1034
  11. Ittel T.H., Clasen W., Fuhs M. et al. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clin. Nephrol. 1995; 44(3): 156-162
  12. Sheashaa H., Mahmoud I., El-Basuony F. et al. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study. Int. Urol. Nephrol. 2007; 39(3): 923-928
  13. Plank C., Kalb V., Hinkes B. et al.; Arbeitsgemeinschaft für Pädiatrische Nephrologie. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr. Nephrol. 2008; 23(9): 1483-1493
  14. Hamasaki Y., Yoshikawa N., Hattori S. et al. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 2009; 24(11): 2177-2185
  15. Frassinetti Castelo Branco Camurça Fernandes P., Bezerra Da Silva G. Jr., De Sousa Barros F.A. et al. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review. J. Nephrol. 2005; 18(6): 711-720
  16. Rasche F.M., Keller F., Kunze G. et al. Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome. Clin. Nephrol. 2007; 67(5): 285-292
  17. Мухин Н.А., Тареева И.Е., Краснова Т.Н., Шилов Е.М., Мирошниченко Н.Г. Лечение нефротической формы хронического гломерулонефрита сандиммуном (циклоспорином А). Тер арх. 1995; 67(8): 13-15
  18. Краснова Т.Н., Тареева И.Е., Шилов Е.М., Мухин Н.А., Мирошниченко Н.Г. Сандиммун в лечении хронического гломерулонефрита с нефротическим синдромом. Тер арх. 1995; 69(6): 21-23
  19. Hodson E.M., Willis N.S., Craig J.C. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst. Rev. 2008; (1):CD002290
  20. Сameron J.S. Focal segmental glomerulosclerosis in adults. Nephrol. Dial. Transplant. 2003; 18 (Suppl. 6): vi45-vi51
  21. Cattran D.C., Appel G.B., Hebert L.A. et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int. 1999; 56(6): 2220-2226
  22. Goumenos D.S., Tsagalis G., El Nahas A.M. et al.Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Nephron. Clin. Pract. 2006; 104(2): c75-c82
  23. Braun N., Schmutzler F., Lange C. et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst. Rev. 2008; (3):CD003233
  24. Waldo F.B., Benfield M.R., Kohaut E.C. et al. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr. Nephrol. 1998; 12(5):397-400
  25. Lieberman K.V., Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J. Am. Soc. Nephrol. 1996; 7(1): 56-63
  26. Mahmoud I., Basuni F., Sabry A. et al. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2005; 20(4): 735-742
  27. Raafat R.H., Kalia A., Travis L.B., Diven S.C. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am. J. Kidney Dis. 2004; 44(1): 50-56
  28. Drube J., Geerlings C., Taylor R. et al. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A. Pediatr. Nephrol. 2007; 22(4): 600-602
  29. Yorgin P.D., Belson A., Higgins J., Alexander S.R. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis. Am. J. Kidney Dis. 2001; 37(6): E44
  30. Chishti A.S., Sorof J.M., Brewer E.D., Kale A.S. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am. J Kidney Dis. 2001; 38(4): 754-760
  31. Goumenos D.S. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert. Opin. Pharmacother. 2008; 9(10): 1695-1704
  32. De Santo N.G., Caposicasa G., Giordano C. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am. J. Nephrol. 1987; 7: 74-76
  33. Meyrier A. Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases. Nephrol. Dial. Transplant. 1992; 7 (Suppl. 1): 80-84
  34. Rostocker G., Belghiti D., Ben Maadi A.D. et al. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993; 63: 335-341
  35. Сattran D.C., Greenwood C., Ritchie S. et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int. 1995; 47: 1130-1135
  36. Ambalavanan S., Fauvel J.P., Sibley R.K., Myers B.D. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J. Am. Soc. Nephrol. 1996; 7(2): 290-298
  37. Goumenos D.S., Kalliakmani P., Tsakas S. et al. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin. Nephrol. 2004; 61(1): 17-24
  38. Alexopoulos E., Papagianni A., Tsamelashvili M. et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol. Dial. Transplant. 2006; 21(11): 3127-3132
  39. Goumenos D.S., Katopodis K.P., Passadakis P. et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am. J. Nephrol. 2007; 27(3): 226-231
  40. Pape L., Mengel M., Offner G., Ehrich J.H. Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child. Nephrol. Dial. Transplant. 2004; 19(12): 3207
  41. Eisterer W., Neyer U., Hilbe W. et al. Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia. Nephron. 1996; 72(3): 468-471
  42. Poncticelli C., Villa M. Does cyclosporin have a role in the treatment of membranous nephropathy? Nephrol. Dial. Transplant. 1999; 14: 23-25
  43. Тареева И.Е., Шилов Е.М., Краснова Т.Н. и др. Волчаночный нефрит в середине XX века и в начале XXI века. Тер. арх. 2001; 73(6): 5 - 10
  44. Ponticelli C., Glassock R.J., Moroni G. Induction and maintenance therapy in proliferative lupus nephritis. J. Nephrol. 2010; 23(01): 9-16
  45. Moroni G., Doria A., Mosca M. et al. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin. J. Am. Soc. Nephrol. 2006; 1(5): 925-932
  46. Ogawa H., Kameda H., Amano K., Takeuchi T. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Lupus. 2010; 19(2): 162-169
  47. Ogawa H., Kameda H., Nagasawa H. et al. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Mod. Rheumatol. 2007;17(2): 92-97
  48. Baca V., Catalán T., Villasís-Keever M. et al. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Lupus. 2006; 15(8): 490-495
  49. Hallegua D., Wallace D.J., Metzger A.L. et al. Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus. 2000;9(4): 241-251
  50. Rihova Z., Vankova Z., Maixnerova D. et al. Treatment of lupus nephritis with cyclosporine - an outcome analysis. Kidney Blood Press. Res. 2007; 30(2): 124-128
  51. Lim B.J., Kim J.H., Hong S.W., Jeong H.J. Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine. Pediatr. Nephrol. 2009; 24(3): 513-519
  52. Kiyomasu T., Shibata M., Kurosu H. et al. Cyclosporin A treatment for membranoproliferative glomerulonephritis type II. Nephron. 2002; 91(3): 509-511
  53. Shin J.I., Park J.M., Shin Y.H. et al. Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome. Pediatr. Nephrol. 2005; 20(8): 1093-1097
  54. Ronkainen J., Autio-Harmainen H., Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr. Nephrol. 2003; 18(11): 1138-1142

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies